Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Gait Deficits and Loss of Striatal Tyrosine Hydroxlase/Trk-B are Restored Following 7,8-Dihydroxyflavone Treatment in a Progressive MPTP Mouse Model of Parkinson’s Disease
Michelle S. Massaquoi, William A. Liguore, Madeline J. Churchill, et al.
Neuroscience (2020) Vol. 433, pp. 53-71
Closed Access | Times Cited: 39

Showing 1-25 of 39 citing articles:

The Role of Brain-Derived Neurotrophic Factor as an Essential Mediator in Neuronal Functions and the Therapeutic Potential of Its Mimetics for Neuroprotection in Neurologic and Psychiatric Disorders
Tadahiro Numakawa, Ryutaro Kajihara
Molecules (2025) Vol. 30, Iss. 4, pp. 848-848
Open Access | Times Cited: 4
Glutathione Depletion and Parkinsonian Neurotoxin MPP+-Induced TRPM2 Channel Activation Play Central Roles in Oxidative Cytotoxicity and Inflammation in Microglia
Kenan Yıldızhan, Mustafa Nazıroğlu
Molecular Neurobiology (2020) Vol. 57, Iss. 8, pp. 3508-3525
Closed Access | Times Cited: 76
Visuo‐spatial learning and memory impairments in the 5xFAD mouse model of Alzheimer's disease: Effects of age, sex, albinism, and motor impairments
Timothy P. O’Leary, Richard E. Brown
Genes Brain & Behavior (2022) Vol. 21, Iss. 4
Open Access | Times Cited: 45
LncRNA HOTAIR Promotes Neuronal Damage Through Facilitating NLRP3 Mediated-Pyroptosis Activation in Parkinson’s Disease via Regulation of miR-326/ELAVL1 Axis
Qian Zhang, Xiao-Mo Huang, Jian-Xiong Liao, et al.
Cellular and Molecular Neurobiology (2020) Vol. 41, Iss. 8, pp. 1773-1786
Closed Access | Times Cited: 46
7,8-Dihydroxyflavone and Neuropsychiatric Disorders: A Translational Perspective from the Mechanism to Drug Development
Guoqi Zhu, Shaojie Yang
Current Neuropharmacology (2021) Vol. 20, Iss. 8, pp. 1479-1497
Open Access | Times Cited: 34
Intranasal delivery of liposome encapsulated flavonoids ameliorates L-DOPA induced dyskinesia in hemiparkinsonian mice
Mohamed Rafiuddin Ahmed, Mohammed Inayathullah, Mithya Morton, et al.
Biomaterials (2024) Vol. 311, pp. 122680-122680
Closed Access | Times Cited: 4
Identifying Key Plasma Proteins in the Onset of Parkinson’s Disease: Proteome-Wide Mendelian Randomization and Single-Cell RNA Sequencing Analysis
Wei Quan, Lin Wang, Jing Xu, et al.
Molecular Neurobiology (2025)
Closed Access
Edaravone alleviated propofol‐induced neural injury in developing rats by BDNF/TrkB pathway
Yangliang Yang, Jing Yi, Mengzhi Pan, et al.
Journal of Cellular and Molecular Medicine (2021) Vol. 25, Iss. 11, pp. 4974-4987
Open Access | Times Cited: 22
Suggesting 7,8-dihydroxyflavone as a promising nutraceutical against CNS disorders
Rajib Paul, Joyobrato Nath, Satinath Paul, et al.
Neurochemistry International (2021) Vol. 148, pp. 105068-105068
Closed Access | Times Cited: 21
Investigating the TLR4/TAK1/IRF7 axis in NLRP3-Mediated Pyroptosis in Parkinson's Disease
Wei Quan, Ying Liu, Jia Li, et al.
Inflammation (2023) Vol. 47, Iss. 1, pp. 404-420
Closed Access | Times Cited: 9
Research on the mechanism of Ursolic acid for treating Parkinson's disease by network pharmacology and experimental verification
Ao Sun, Yufei Li, Yang Miao, et al.
Heliyon (2024) Vol. 10, Iss. 14, pp. e34113-e34113
Open Access | Times Cited: 3
Differential ultrastructural alterations in the Vglut2 glutamatergic input to the substantia nigra pars compacta/pars reticulata following nigrostriatal dopamine loss in a progressive mouse model of Parkinson’s disease
Cindy Moore, Mo Xu, Jerry K. Bohlen, et al.
European Journal of Neuroscience (2020) Vol. 53, Iss. 7, pp. 2061-2077
Closed Access | Times Cited: 22
7,8-dihydroxyflavone ameliorates motor deficits via regulating autophagy in MPTP-induced mouse model of Parkinson’s disease
Li Zuo, Chunfang Dai, Lilin Yi, et al.
Cell Death Discovery (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 16
Identification of Potential Core Genes in Parkinson’s Disease Using Bioinformatics Analysis
Wei Quan, Jia Li, Xiya Jin, et al.
Parkinson s Disease (2021) Vol. 2021, pp. 1-10
Open Access | Times Cited: 15
Causal role of myeloid cells in Parkinson’s disease: Mendelian randomization study
Wei Quan, Yidan Qin, Jia Li, et al.
Inflammation Research (2024) Vol. 73, Iss. 5, pp. 809-818
Closed Access | Times Cited: 2
Influence of N6-Methyladenosine Modification Gene HNRNPC on Cell Phenotype in Parkinson’s Disease
Wei Quan, Jia Li, Li Liu, et al.
Parkinson s Disease (2021) Vol. 2021, pp. 1-10
Open Access | Times Cited: 14
7,8-Dihydroxiflavone protects retinal ganglion cells and promotes axonal regeneration through TrkB signaling pathway followed by AKT and ERK activation
Xiangwu Chen, Shuqi You, Qing Xia, et al.
Neuroscience Research (2023) Vol. 193, pp. 52-62
Closed Access | Times Cited: 5
Pyroptosis in neurodegenerative diseases: What lies beneath the tip of the iceberg?
Mengli Yue, Xiao Li, Rui Yan, et al.
International Reviews of Immunology (2022) Vol. 42, Iss. 4, pp. 258-273
Closed Access | Times Cited: 7
Neuroprotective effect of hyperoside in MPP+/MPTP -induced dopaminergic neurodegeneration
Xing-Jie Xu, Tao Pan, Huijie Fan, et al.
Metabolic Brain Disease (2022) Vol. 38, Iss. 3, pp. 1035-1050
Closed Access | Times Cited: 7
Aged xCT-Deficient Mice Are Less Susceptible for Lactacystin-, but Not 1-Methyl-4-Phenyl-1,2,3,6- Tetrahydropyridine-, Induced Degeneration of the Nigrostriatal Pathway
Eduard Bentea, Laura De Pauw, Lise Verbruggen, et al.
Frontiers in Cellular Neuroscience (2021) Vol. 15
Open Access | Times Cited: 6
Recovery of motor function is associated with rescue of glutamate biomarkers in the striatum and motor cortex following treatment with Mucuna pruriens in a murine model of Parkinsons disease
Tanya Denne, Lila C. Winfrey, Cindy Moore, et al.
Molecular and Cellular Neuroscience (2023) Vol. 126, pp. 103883-103883
Closed Access | Times Cited: 2
Effects of aerobic exercise and dietary flavonoids on cognition: a systematic review and meta-analysis
Daren Kumar Joseph, Arimi Fitri Mat Ludin, Farah Wahida Ibrahim, et al.
Frontiers in Physiology (2023) Vol. 14
Open Access | Times Cited: 1
Enhancement of response learning in male rats with intrastriatal infusions of a BDNF - TrkB agonist, 7,8-dihydroxyflavone
Robert S. Gardner, Matthew T. Ambalavanar, Paul E. Gold, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Dopamine loss alters glutamate synapses and transporters in the medial prefrontal cortex and anxiety‐related behaviour in a male MPTP rodent model of Parkinson's disease
Cindy Moore, Melinda L. Helms, Michelle A. Nipper, et al.
European Journal of Neuroscience (2024)
Closed Access
Assessment of the toxicity and toxicokinetics of the novel potent tropomyosin receptor kinase (Trk) inhibitor LPM4870108 in rhesus monkeys
Sijin Duan, Lin Dong, Bingsi Wang, et al.
Regulatory Toxicology and Pharmacology (2021) Vol. 122, pp. 104886-104886
Closed Access | Times Cited: 3
Page 1 - Next Page

Scroll to top